• Reading Note
Iovance brings cell therapy to solid tumors
Immune cell therapy — the use of modified immune cells directly to control cancer and autoimmune disease — has shown incredible results in liquid tumors (cancers of the blood and bone marrow like lymphoma, leukemia, etc), but has stumbled in addressing solid tumors. Iovance, which recently had its drug lifileucel approved by the FDA to treat advanced melanoma, has demonstrated...